Anisha B Dua,Jeffrey A Sparks
Anisha B Dua
Newer Immunosuppressants for Rheumatologic Disease: Preoperative Considerations [0.03%]
风湿性疾病免疫抑制剂的围术期考虑因素
Ye Rin Koh,Kenneth C Cummings rd
Ye Rin Koh
With the advent of small-molecule immune modulators, recombinant fusion proteins, and monoclonal antibodies, treatment options for patients with rheumatic diseases are now broad. These agents carry significant risks and an individualized ap...
William S Frye,Diana Milojevic
William S Frye
Pediatric rheumatic diseases (PRDs) are a heterogeneous group of diseases that can have a chronic unpredictable disease course that can negatively affect mood, functioning, and quality of life. Given the range of difficulties faced in manag...
Sonal Pruthi,Emaad Siddiqui,Nathaniel R Smilowitz
Sonal Pruthi
Ischemic heart disease (IHD) affects more than 20 million adults in the United States. Although classically attributed to atherosclerosis of the epicardial coronary arteries, nearly half of patients with stable angina and IHD who undergo in...
Win Min Oo
Win Min Oo
Osteoarthritis (OA) causes a massive disease burden with a global prevalence of nearly 23% in 2020 and an unmet need for adequate treatment, given a lack of disease-modifying drugs (DMOADs). The author reviews the prospects of active DMOAD ...
Aurea Valeria Rosa Mohana-Borges,Christine B Chung
Aurea Valeria Rosa Mohana-Borges
Imaging methods capable of detecting inflammation, such as MR imaging and ultrasound, are of paramount importance in rheumatic disease management, not only for diagnostic purposes but also for monitoring disease activity and treatment respo...
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease [0.03%]
与结缔组织病相关的间质性肺疾病的临床相关生物标志物
Janelle Vu Pugashetti,Dinesh Khanna,Ella A Kazerooni et al.
Janelle Vu Pugashetti et al.
Interstitial lung disease (ILD) complicates connective tissue disease (CTD) with variable incidence and is a leading cause of death in these patients. To improve CTD-ILD outcomes, early recognition and management of ILD is critical. Blood-b...
Scott M Matson,M Kristen Demoruelle
Scott M Matson
Connective tissue disease associated interstitial lung disease (CTD-ILD) is a heterogenous collection of conditions with a diverse spectrum of interstitial lung disease (ILD) manifestations. Currently, clinical practice of lung-directed imm...
Kimberly Kallianos
Kimberly Kallianos
The majority of connective tissue diseases (CTDs) are multisystem disorders that are often heterogeneous in their presentation and do not have a single laboratory, histologic, or radiologic feature that is defined as the gold standard to su...
Syed Rafay A Sabzwari,Wendy S Tzou
Syed Rafay A Sabzwari
Systemic diseases can cause heart block owing to the involvement of the myocardium and thereby the conduction system. Younger patients (